These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 18554199)
21. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia. Celiker A; Erdoğan I; Karagöz T; Ozer S Cardiol Young; 2009 Feb; 19(1):45-52. PubMed ID: 19102802 [TBL] [Abstract][Full Text] [Related]
22. Sudden cardiac arrest during sex in patients with either catecholaminergic polymorphic ventricular tachycardia or long-QT syndrome: a rare but shocking experience. Loar RW; Bos JM; Cannon BC; Ackerman MJ J Cardiovasc Electrophysiol; 2015 Mar; 26(3):300-4. PubMed ID: 25514987 [TBL] [Abstract][Full Text] [Related]
23. [Catecholaminergic polymorphic ventricular tachycardia in adult: a case report]. Ben Ameur Y; Kamoun S; Ben Moussa F; Battikh K; Longo S; Ben Youssef I; Slimane ML Tunis Med; 2010 May; 88(5):349-52. PubMed ID: 20517833 [TBL] [Abstract][Full Text] [Related]
25. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report. Garabedian L; Verryckt A; Panzer J; De Wolf D Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993 [TBL] [Abstract][Full Text] [Related]
26. Syncope during exercise: just another benign vasovagal event? Bat T; Collins KK; Schaffer MS Curr Opin Pediatr; 2011 Oct; 23(5):573-5. PubMed ID: 21743327 [TBL] [Abstract][Full Text] [Related]
27. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia. Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201 [TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. van der Werf C; Lieve KV; Bos JM; Lane CM; Denjoy I; Roses-Noguer F; Aiba T; Wada Y; Ingles J; Leren IS; Rudic B; Schwartz PJ; Maltret A; Sacher F; Skinner JR; Krahn AD; Roston TM; Tfelt-Hansen J; Swan H; Robyns T; Ohno S; Roberts JD; van den Berg MP; Kammeraad JA; Probst V; Kannankeril PJ; Blom NA; Behr ER; Borggrefe M; Haugaa KH; Semsarian C; Horie M; Shimizu W; Till JA; Leenhardt A; Ackerman MJ; Wilde AA Eur Heart J; 2019 Sep; 40(35):2953-2961. PubMed ID: 31145795 [TBL] [Abstract][Full Text] [Related]
29. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262 [TBL] [Abstract][Full Text] [Related]
30. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening. Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799 [TBL] [Abstract][Full Text] [Related]
32. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations. de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293 [TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665 [TBL] [Abstract][Full Text] [Related]
34. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. Wilde AA; Bhuiyan ZA; Crotti L; Facchini M; De Ferrari GM; Paul T; Ferrandi C; Koolbergen DR; Odero A; Schwartz PJ N Engl J Med; 2008 May; 358(19):2024-9. PubMed ID: 18463378 [TBL] [Abstract][Full Text] [Related]
36. S4153R is a gain-of-function mutation in the cardiac Ca(2+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation. Zhabyeyev P; Hiess F; Wang R; Liu Y; Wayne Chen SR; Oudit GY Can J Cardiol; 2013 Aug; 29(8):993-6. PubMed ID: 23498838 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia. Andrsova I; Valaskova I; Kubus P; Vit P; Gaillyova R; Kadlecova J; Manouskova L; Novotny T Pacing Clin Electrophysiol; 2012 Jul; 35(7):798-803. PubMed ID: 22519458 [TBL] [Abstract][Full Text] [Related]
38. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope. Mok NS; Lam CW; Fong NC; Hui YW; Choi YC; Chan KY Chin Med J (Engl); 2006 Dec; 119(24):2129-33. PubMed ID: 17199967 [No Abstract] [Full Text] [Related]
39. Genetic characterization of familial CPVT after 30 years. Beery TA; Shah MJ; Benson DW Biol Res Nurs; 2009 Jul; 11(1):66-72. PubMed ID: 19398417 [TBL] [Abstract][Full Text] [Related]
40. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Pflaumer A; Davis AM Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]